Relief in South Africa after J&J reversal allows key tuberculosis drug production at lower prices

CAPE TOWN, South Africa (AP) — Medical advocacy groups have welcomed Johnson & Johnson’s decision not to enforce its patent on a critical tuberculosis medication, allowing its production at much lower prices, after South African authorities opened an investigation into the conglomerate. ...